Jointown Pharmaceutical Group Co., Ltd

Shanghai Stock Exchange 600998.SS

Jointown Pharmaceutical Group Co., Ltd EBT Margin for the year ending December 31, 2023: 1.99%

Jointown Pharmaceutical Group Co., Ltd EBT Margin is 1.99% for the year ending December 31, 2023, a -1.44% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Jointown Pharmaceutical Group Co., Ltd EBT Margin for the year ending December 31, 2022 was 2.02%, a -26.44% change year over year.
Jointown Pharmaceutical Group Co., Ltd EBT Margin for the year ending December 31, 2021 was 2.75%, a -29.72% change year over year.
Jointown Pharmaceutical Group Co., Ltd EBT Margin for the year ending December 31, 2020 was 3.91%, a 67.85% change year over year.
Jointown Pharmaceutical Group Co., Ltd EBT Margin for the year ending December 31, 2019 was 2.33%, a 10.86% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Shanghai Stock Exchange: 600998.SS

Jointown Pharmaceutical Group Co., Ltd

CEO	Mr. Wei He
IPO Date	Nov. 2, 2010
Location	China
Headquarters	No. 8, Longyang Avenue
Employees	30,100
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.

Key trends

Past 5 years